Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.

Wozny AS, Lauret A, Battiston-Montagne P, Guy JB, Beuve M, Cunha M, Saintigny Y, Blond E, Magne N, Lalle P, Ardail D, Alphonse G, Rodriguez-Lafrasse C.

Br J Cancer. 2017 May 9;116(10):1340-1349. doi: 10.1038/bjc.2017.100. Epub 2017 Apr 13.

2.

Oocytes and early embryos selectively express the survival factor BCL2L10.

Guillemin Y, Lalle P, Gillet G, Guerin JF, Hamamah S, Aouacheria A.

J Mol Med (Berl). 2009 Sep;87(9):923-40. doi: 10.1007/s00109-009-0495-7. Epub 2009 Jun 24.

PMID:
19551325
3.

Modulating mitochondria-mediated apoptotic cell death through targeting of Bcl-2 family proteins.

Aouacheria A, Cibiel A, Guillemin Y, Gillet G, Lalle P.

Recent Pat DNA Gene Seq. 2007;1(1):43-61. Review.

PMID:
19075918
4.

Modulation of Nr-13 antideath activity by peptide aptamers.

Nouvion AL, Thibaut J, Lohez OD, Venet S, Colas P, Gillet G, Lalle P.

Oncogene. 2007 Feb 1;26(5):701-10. Epub 2006 Aug 14.

PMID:
16909120
5.

Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.

Thorel F, Constantinou A, Dunand-Sauthier I, Nouspikel T, Lalle P, Raams A, Jaspers NG, Vermeulen W, Shivji MK, Wood RD, Clarkson SG.

Mol Cell Biol. 2004 Dec;24(24):10670-80.

6.

Evidence for crucial electrostatic interactions between Bcl-2 homology domains BH3 and BH4 in the anti-apoptotic Nr-13 protein.

Lalle P, Aouacheria A, Dumont-Miscopein A, Jambon M, Venet S, Bobichon H, Colas P, Deléage G, Geourjon C, Gillet G.

Biochem J. 2002 Nov 15;368(Pt 1):213-21.

7.

The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.

Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG.

J Invest Dermatol. 2002 Feb;118(2):344-51.

8.

Nrh, a human homologue of Nr-13 associates with Bcl-Xs and is an inhibitor of apoptosis.

Aouacheria A, Arnaud E, Venet S, Lalle P, Gouy M, Rigal D, Gillet G.

Oncogene. 2001 Sep 13;20(41):5846-55.

9.
10.

Conserved residues of human XPG protein important for nuclease activity and function in nucleotide excision repair.

Constantinou A, Gunz D, Evans E, Lalle P, Bates PA, Wood RD, Clarkson SG.

J Biol Chem. 1999 Feb 26;274(9):5637-48.

11.
12.

High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.

Cornelis RS, Neuhausen SL, Johansson O, Arason A, Kelsell D, Ponder BA, Tonin P, Hamann U, Lindblom A, Lalle P, et al.

Genes Chromosomes Cancer. 1995 Jul;13(3):203-10.

PMID:
7669740
13.

Genomic stability and wild-type p53 function of lymphoblastoid cells with germ-line p53 mutation.

Lalle P, Moyret-Lalle C, Wang Q, Vialle JM, Navarro C, Bressac-de Paillerets B, Magaud JP, Ozturk M.

Oncogene. 1995 Jun 15;10(12):2447-54.

PMID:
7784096
14.

Lack of germ-line mutations in the p53 gene exons 4 to 8 in patients with late-onset second malignant neoplasms.

Lalle P, Moyret C, Bignon YJ.

Cancer Genet Cytogenet. 1994 Sep;76(2):148-50.

PMID:
7923066
15.

Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.

Mazoyer S, Lalle P, Moyret-Lalle C, Marçais C, Schraub S, Frappaz D, Sobol H, Ozturk M.

Oncogene. 1994 Apr;9(4):1237-9.

PMID:
8134127
16.
17.

[Hereditary predisposition for cancer of the breast and the ovary].

Lalle P, Stoppa-Lyonnet D, Mazoyer S, Rio P, Girodet C, Hardouin A, Narod SA, Sobol H, Bignon YJ.

Bull Cancer. 1993 Oct;80(10):857-65. French.

PMID:
8204923
18.

Screening of inherited breast cancer with DNA markers.

Lalle P, Bignon YJ, Stoppa-Lyonnet D, Narod SA, Mazoyer S, Rio P, Courjal F, Bartholin P, Sobol H.

Lancet. 1993 May 29;341(8857):1422. No abstract available.

PMID:
8098837
19.

Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.

Mazoyer S, Lalle P, Narod SA, Bignon YJ, Courjal F, Jamot B, Dutrillaux B, Stoppa-Lyonnett D, Sobol H.

Am J Hum Genet. 1993 Apr;52(4):754-60.

20.

XPERT NCT--a clinical evaluation.

Myers KJ, Lalle P, Litwak A, Campbell S, Ballinger R, Grolman B.

J Am Optom Assoc. 1990 Nov;61(11):863-9.

PMID:
2081831
21.

How reliable is the Goldmann tonometer as a standard?

Grolman B, Myers KJ, Lalle P.

J Am Optom Assoc. 1990 Nov;61(11):857-62.

PMID:
2081830
22.

Automated perimetry in the management of glaucoma.

Lalle PA, Fingeret M, Eiden SB.

J Am Optom Assoc. 1989 Dec;60(12):900-11. Review.

PMID:
2693510
23.

Central retinal vein occlusion and iris neovascularization hemorrhage.

Myers KJ, Lalle PA.

J Am Optom Assoc. 1988 Oct;59(10):787-90.

PMID:
2460514
24.

Unilateral lattice dystrophy of the cornea.

Harding RG, Lalle PA, Kasik KA.

J Am Optom Assoc. 1982 Jun;53(6):477-9. No abstract available.

PMID:
6980910

Supplemental Content

Support Center